Dr. Brad Rovin, director of the Division of Nephrology and the Vice Chair of Research in Internal Medicine at the Ohio State University, discusses recent advances in lupus nephritis treatment. Dr. Rovin is deputy editor of Kidney International and the co-chair of glomerular disease guidelines for KDIGO. He has published many major landmark nephrology clinical trials in lupus nephritis (listed below), which he highlights in this episode. It's the "golden age" of lupus nephritis treatment!
Papers we discuss:
BLISS (Belimumab) https://www.nejm.org/doi/full/10.1056/NEJMoa2001180
AURORA (Voclosporin) https://www.thelancet.com/article/S0140-6736(21)00578-X/fulltext
LUNAR (Rituximab) https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.34359
NOBILITY (Obinutuzumab) https://ard.bmj.com/content/81/1/100
TULIP-LN (Anifrolumab) https://ard.bmj.com/content/81/4/496
Also check out https://kidney.wiki/ pediatric nephrology platform created by Ryan Town, a fellow from Stanford!
